
Loading, please wait...

Loading, please wait...

Evidence from population studies and international guidelines shows that cervical cancer prevention is strongest when primary prevention with HPV vaccination is combined with organized screening and treatment of precancerous lesions. HPV vaccination reduces infection with major oncogenic HPV types, but it does not eliminate the need for screening because not all cancer-causing types are covered and vaccination does not clear established infection. For gynecologists, an effective elimination pathway therefore depends on high vaccine uptake, accessible HPV-based screening and reliable follow-up of positive tests. The clinical challenge is often program implementation rather than the biological efficacy of the interventions. In India, opportunities include integrating adolescent vaccination with school and community health systems and strengthening screening among adult women. This combined prevention model aligns closely with AICOG's focus on improving women's health at population scale.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Evidence from population studies and international guidelines shows that cervical cancer prevention is strongest when primary prevention with HPV vaccination is combined with organized screening and treatment of precancerous lesions. HPV vaccination reduces infection with major oncogenic HPV types, but it does not eliminate the need for screening because not all cancer-causing types are covered and vaccination does not clear established infection. For gynecologists, an effective elimination pathway therefore depends on high vaccine uptake, accessible HPV-based screening and reliable follow-up of positive tests. The clinical challenge is often program implementation rather than the biological efficacy of the interventions. In India, opportunities include integrating adolescent vaccination with school and community health systems and strengthening screening among adult women. This combined prevention model aligns closely with AICOG's focus on improving women's health at population scale.
4 weeks back

Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back

A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month

Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back